£24.99 each or £20 each when purchasing 3 or more!

The COVID-19 IgG/IgM (Whole Blood/Serum/Plasma) Rapid Test Device utilizes lateral flow technology for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies. In general, antibodies can be detected 1-3 weeks after infection. This test is intended to screen patients for SARS-CoV-2 antibodies.

Features 

• Detection Window (IgM): 3-5 days after incubation 

• Dual band results for simple interpretation

• Multivariable analysis of immunoglobin IgG & IgM

• Room temperature storage or refrigerated (2-30⁰C / 36-86⁰F)

• Procedural internal control included

• Buffer included

Specifications

• Clinical Evaluation

  • Positive Percent Agreement (PPA): IgG 96.7%; IgM 86.7%; Overall 96.7%

  • Negative  Percent Agreement (NPA): IgG 98.0%; IgM 99.0%; Overall 97.0%

• Clinical Agreement with Characterized Samples

  • Sensitivity: IgG 96.7%; IgM 100%; Combined 100%

  • Specificity: IgG 97.5%; IgM 100%; Combined 97.5%

• Specimen: Whole Blood, Serum, Plasma

• Time to Results: 10 minutes

• Shelf Life: 24 months from the date of manufacture